Glipizide NDC 69584-309

Product information

Brand name (proprietary)

Glipizide

Generic name (nonproprietary)

glipizide

Active ingredients

Glipizide — 5 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Oxford Pharmaceuticals, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 074378

Marketing start

May 1, 2025

Listing expires

Dec 31, 2027

Other FDA classes

Sulfonylurea Compounds (Chemical structure)

Identifiers

Product ID 69584-309_02a8d094-c2c7-436e-b77e-9889345be1f2SPL ID 02a8d094-c2c7-436e-b77e-9889345be1f2

Pharmacologic class

Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469584030909 followed by a unit qualifier and the quantity Copy

Package 69584-0309-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 074378

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.